BACKGROUND: Recent legislation in the US requires that all medical records become electronic over the next decade. In addition, ongoing developments in patient-oriented care, most notably with the advent of health social networking and personal health records, provide a plethora of new information sources for research. CONTENT: Electronic health records (EHRs) show great potential for use in observational studies to examine drug safety via pharmacovigiliance methods that can find adverse drug events as well as expand drug safety profiles. EHRs also show promise for head-to-head comparative effectiveness trials and could play a critical role in secondary and tertiary diabetes prevention efforts. A growing subset of EHRs, personal health records (PHRs), opens up the possibility of engaging patients in their care, as well as new opportunities for participatory research and personalized medicine. Organizations nationwide, from providers to employers, are already investing heavily in PHR systems. Additionally, the explosive use of online social networking sites and mobile technologies will undoubtedly play a role in future research efforts by making available a veritable flood of information, such as real-time exercise monitoring, to health researchers. SUMMARY: The future confluence of health information technologies will enable researchers and clinicians to reveal novel therapies and insights into treatments and disease management, as well as environmental and genomic interactions, at an unprecedented population scale.
BACKGROUND: Recent legislation in the US requires that all medical records become electronic over the next decade. In addition, ongoing developments in patient-oriented care, most notably with the advent of health social networking and personal health records, provide a plethora of new information sources for research. CONTENT: Electronic health records (EHRs) show great potential for use in observational studies to examine drug safety via pharmacovigiliance methods that can find adverse drug events as well as expand drug safety profiles. EHRs also show promise for head-to-head comparative effectiveness trials and could play a critical role in secondary and tertiary diabetes prevention efforts. A growing subset of EHRs, personal health records (PHRs), opens up the possibility of engaging patients in their care, as well as new opportunities for participatory research and personalized medicine. Organizations nationwide, from providers to employers, are already investing heavily in PHR systems. Additionally, the explosive use of online social networking sites and mobile technologies will undoubtedly play a role in future research efforts by making available a veritable flood of information, such as real-time exercise monitoring, to health researchers. SUMMARY: The future confluence of health information technologies will enable researchers and clinicians to reveal novel therapies and insights into treatments and disease management, as well as environmental and genomic interactions, at an unprecedented population scale.
Authors: Louis Mayaud; Peggy S Lai; Gari D Clifford; Lionel Tarassenko; Leo Anthony Celi; Djillali Annane Journal: Crit Care Med Date: 2013-04 Impact factor: 7.598
Authors: Sebastian Mate; Felix Köpcke; Dennis Toddenroth; Marcus Martin; Hans-Ulrich Prokosch; Thomas Bürkle; Thomas Ganslandt Journal: PLoS One Date: 2015-01-14 Impact factor: 3.240
Authors: Maree Johnson; Samuel Lapkin; Vanessa Long; Paula Sanchez; Hanna Suominen; Jim Basilakis; Linda Dawson Journal: BMC Med Inform Decis Mak Date: 2014-10-28 Impact factor: 2.796
Authors: Titus Kl Schleyer; Alan Ruttenberg; William Duncan; Melissa Haendel; Carlo Torniai; Amit Acharya; Mei Song; Thankam P Thyvalikakath; Kaihong Liu; Pedro Hernandez Journal: AMIA Jt Summits Transl Sci Proc Date: 2013-03-18